INITIAL PHASE-II CLINICAL-STUDIES ON MIDAGLIZOLE (DG-5128) - A NEW HYPOGLYCEMIC AGENT

被引：40

作者：

KAWAZU, S

SUZUKI, M

NEGISHI, K

ISHII, J

SANDO, H

KATAGIRI, H

KANAZAWA, Y

YAMANOUCHI, S

AKANUMA, Y

KAJINUMA, H

SUZUKI, K

WATANABE, K

ITOH, T

KOBAYASHI, T

KOSAKA, K

机构：

[1] NATL MED CTR HOSP, TOKYO, JAPAN

[2] UNIV TOKYO, FAC MED, DEPT INTERNAL MED 3, TOKYO 113, JAPAN

[3] ASAMI LIFE FDN, INST ADULT DIS, TOKYO, JAPAN

[4] TORANOMON HOSP, TOKYO 107, JAPAN

来源：

DIABETES | 1987年 / 36卷 / 02期

关键词：

D O I：

10.2337/diabetes.36.2.221

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：221 / 226

页数：6

共 23 条

[1]

FIELD M, 1973, AM J PHYSIOL, V225, P852

[2]

KADOWAKI T, 1984, DIABETOLOGIA, V26, P44, DOI 10.1007/BF00252262

[3] INSULIN RELEASING ACTION OF 2-[2-(4,5-DIHYDRO-1H-IMADAZOL-2-YL)-1-PHENYLETHYL] PYRIDINE DIHYDROCHLORIDE SESQUIHYDRATE (DG-5128), A NEW, ORALLY EFFECTIVE HYPOGLYCEMIC AGENT [J].

KAMEDA, K ;

ONO, S ;

KOYAMA, I ;

ABIKO, Y .

ACTA ENDOCRINOLOGICA, 1982, 99 (03) :410-415

[4]

KAMEDA K, 1982, ARZNEIMITTEL-FORSCH, V32-1, P39

[5]

KAMEDA KY, 1981, BIOCHIM BIOPHYS ACTA, V677, P263

[6]

KAWAZU S, 1984, Journal of the Japan Diabetes Society, V27, P803

[7] STUDIES OF MIDAGLIZOLE (DG-5128) - A NEW TYPE OF ORAL HYPOGLYCEMIC DRUG IN HEALTHY-SUBJECTS [J].

KAWAZU, S ;

SUZUKI, M ;

NEGISHI, K ;

WATANABE, T ;

ISHII, J .

DIABETES, 1987, 36 (02) :216-220

[8]

KNUDTZON J, 1983, DIABETOLOGIA, V25, P171

[9] INSULIN-LIKE ACTIVITY IN PANCREATIC VEIN BLOOD AFTER GLUCOSE LOADING + EPINEPHRINE HYPERGLYCEMIA [J].

KOSAKA, K ;

KUZUYA, N ;

KUZUYA, T ;

OKINAKA, S ;

MIKI, E ;

IDE, T .

ENDOCRINOLOGY, 1964, 75 (01) :9-&

[10]

Kosaka K, 1982, J JAPAN DIAB SOC, V25, P859

← 1 2 3 →